The International Conference on Biologics, Biosimilars and Biopharmaceuticals (October 01-02, 2026, Chicago, USA) is a premier global forum designed to bring together researchers, scientists, industry leaders, clinicians, and policymakers to explore the latest developments and innovations in the biopharmaceutical sector.
This conference provides a unique platform to share cutting-edge research, discuss challenges, and explore emerging trends in biologics, biosimilars, and advanced biopharmaceutical technologies. Participants will have opportunities to present their research, engage in thought-provoking discussions, and network with leading experts from around the world.
Key focus areas include:
a. Biologics: Therapeutic Proteins and Monoclonal Antibodies
b. Biosimilars Development, Regulatory Landscape, and Clinical Studies
c. Biopharmaceutical Manufacturing, Quality Control, and Process Innovation
d. Advanced Therapeutics: Cell and Gene Therapy, mRNA, and RNA Therapeutics
e. Drug Delivery, Formulation, and Analytical Characterization
f. Regulatory Compliance, Intellectual Property, and Policy Issues
g. Emerging Technologies, Nanotechnology, and Digitalization in Biopharmaceuticals
The conference aims to foster collaboration, inspire innovation, and accelerate the translation of scientific discoveries into practical healthcare solutions. Join us in Chicago to be part of a transformative event shaping the future of biopharmaceutical science.